A previously underappreciated part of the body’s natural defense against SARS-CoV-2, called non-RBD-directed antibodies, actually plays a major role in combating the virus, according to a new study. That’s good news for scientists designing the next generation of vaccines to protect against variants of the virus or future emerging coronaviruses.